68 results
Page 3 of 4
6-K
EX-99.1
9bvfie7er7ab hm6
9 Feb 21
Innate Pharma Advances Lacutamab Clinical Development Program
6:30am
F-3
t79sxndrog
13 Jan 21
Shelf registration (foreign)
1:59pm
6-K
EX-99.1
uslcrery
17 Nov 20
Innate Pharma Reports Third Quarter 2020 Financial Results and Business Update
6:30am
6-K
EX-99.1
ymqrf cnue6x
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
6-K
EX-99.2
bwz53ai5iho3r12
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
6-K
EX-99.1
1saf53g
29 Jul 20
Innate Pharma Announces Publication of EXPLORE COVID-19 Translational Study Findings in Nature
6:30am
6-K
EX-99.1
3gi77vr4ohuos4 p2sh
16 Jul 20
Innate Pharma Announces the Appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer
6:30am
6-K
EX-99.1
t837o w2f
24 Jun 20
Current report (foreign)
6:30am
20-F
o7bgkksl7lb8i iho
24 Apr 20
Annual report (foreign)
10:43am
6-K
EX-99.1
g50u7z25p zu9ny56og
10 Mar 20
Current report (foreign)
6:30am
6-K
EX-99.1
jwibl60jkhr0ymj20
10 Mar 20
Innate Pharma Reports Full Year 2019 Financial Results and Business Update
6:30am
6-K
EX-99.2
9ixgg98tvhp5sqnfxfl9
6 Dec 19
Current report (foreign)
4:20pm
424B4
yt6xgm p2osbn1
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
wm3b1fzd
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
EX-10.3
m0mh987w n6j03
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.4
t9guof 2cue
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.2
pskd7d2g
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
yqw5lc32pz3ugslr2zv
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.1
xb3buf tq
20 Sep 19
Registration statement (foreign)
4:08pm